Chanel reports 28% profit drop as global sales slide amid economic pressures

The downturn has cast uncertainty over Chanel’s pricing strategy, as the brand typically raises its prices twice a year, in March and September. Whether it will stick to this practice remains to be seen.

WT default author logo
Women's Tabloid News Desk

Chanel has reported a sharp 28.2% decline in net profit for 2024, bringing earnings down to $3.4 billion as the French luxury giant grapples with tough economic conditions across key markets.

Global revenue went down by 5.3% to $18.7 billion. “We saw challenging macroeconomic conditions which had an impact on sales in some markets,” said the CEO of the fashion house, Leena Nair. 

The downturn has cast uncertainty over Chanel’s pricing strategy, as the brand typically raises its prices twice a year, in March and September. Whether it will stick to this practice remains to be seen.

Other luxury houses such as Hermès have already pushed prices up, partly in response to the 10% tariffs on imports into the US introduced by President Donald Trump.  Commenting on the matter, Chanel CFO Philippe Blondiaux said the tariff situation was “extremely volatile” and added, “we are waiting to see what will be the outcome of all the ongoing discussions” before taking a decision.

Regionally, Chanel’s 2024 sales in North and South America fell by 4.3%, while the Asia-Pacific region saw a steeper decline of 9.3%. Europe, however, recorded a slight rise of 1.2% in sales.

Despite the decline, Chanel made “record” investments last year, acquiring prime properties in Paris and New York and expanding its store footprint in China and Japan. Plans are in place to continue growing in China, as well as in India and Mexico.

Share:

Related Insights

Riedel Group appoints Gudrun Scharler as the new CEO of Riedel Networks

Intention.ly secures official Women’s Business Enterprise certification from WBENC

London-based children’s nutrition brand Lune & Wild secures £2 million in Series A funding round

Corlytics appoints Lisa Miles-Heal as Chief Executive Officer to drive next growth phase

Connecticut Science Center secures long-term Aetna partnership for youth training

Aspira and Cleveland Clinic sign AI diagnostics research deal

New property venture Art Deco Freak targets dual-market historic renovations

Zentalis Pharmaceuticals appoints Shannon Campbell and Sarah Kelly to key commercial leadership roles